Since its founding in 2003, Reprocell Co., Ltd. has been engaged in research and development related to ES cells and iPS cells for many years, and its cell culture fluid has been used in the research of Nobel Prize-winning Professoe Yamanaka. To date, Reprocell’s products have been cited in more than 6000 papers (as of November 2020).

Personal iPS is a registered trade mark owned by Riprocell I Co., Ltd., and is a service created by consolidating cutting-edge technology not only from Japan but also from around the world. Since its founding in 2003, Reprocell Co., Ltd. has been engaged in research and development related to ES cells and iPS cells for many years, and its cell culture fluid has been used in the research of Nobel Prize-winning Professoe Yamanaka. To date, Reprocell’s products have been cited in more than 6000 papers (as of November 2020).

Location

〒222-0033
MetLife Shin-yokohama Bldg. 9F 3-8-11 Shin-yokohama Kohoku-ku Yokohama

Website

https://en.personalips.com/contact/

Available Programs

• Personal iPS

  We recommend you to generate and store iPS cell for future medical treatment.

  iPS cells are expected to be used in a variety of treatment, and medical treatments or clinical trials (administration to humans) using iPS cells　have started in Japan, Europe, and the United States. A future where diseases that were once untreatable can be cured by regenerative medicine using iPS cells is becoming a reality. It is important for the treatment of disease and injury to provide appropriate treatment promptly at the necessary time. However, it is reported that iPS cells used in regenerative medicine take time to be produced and along with cell’s aging, production efficiency decreases. Storing personal iPS cells in advance can shorten the preparation time by the start of the treatment, which means treatment can be started quickly. We recommend you to prepare it for the future.

  View Details